Medical utility of glycan-binding proteins and glycans

摘要

NZ 599153 Disclosed is a use of an N-glycan for the preparation of a medicament for use in the treatment and/or prevention of helminthic infections, wherein the N-glycan is selected from the group consisting of D-galacto-pyranosyl-&bgr;-1,4-L-fucopyranosyl-containing oligo/polysaccharides and/or glycoconjugates, D-galacto-pyranosyl-&bgr;-1,4-L-fucopyranosyl- α-1,6-GlcNAc-containing oligo/polysaccharides and/or glycoconjugates, and GnGnF6Gal- and/or MMF6Gal-containing oligosaccharides and glycoconjugates.